Forschungsschwerpunkte
Wir beschäftigen uns mit folgenden Themen:
- Genetische und funktionale Charakterisierung von Resistenzmechanismen bei Gram-negativen Bakterien
- Molekulare Epidemiologie Gram-negativer Erreger nosokomialer Infektionen
- Pathogenitätsfaktoren von Staphylococcus saprophyticus und Staphylococcus lugdunensis
Aktuelle Publikationen
2023:
Hamprecht A, Sattler J, Noster J, Stelzer Y, Fuchs F, Dorth V, Gatermann SG, Göttig
S.:
Proteus mirabilis - analysis of a concealed source of carbapenemases and development
of a diagnostic algorithm for detection.
Clin Microbiol Infect. 2023 Jun 2:S1198-743X(23)00256-2.
Wohlfarth E, Kresken M, Deuchert F, Gatermann SG, Pfeifer Y, Pfennigwerth N, Seifert H,
Higgins PG, Werner G, Study Group 'Antimicrobial Resistance' Of The Paul Ehrlich Society For
Infection Therapy:
In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating
from Germany in 2016/17.
Antibiotics (Basel). 2023 May 6;12(5):864.
Dortet L, Niccolai C, Pfennigwerth N, Frisch S, Gonzalez C, Antonelli A, Giani T, Hoenings R,
Gatermann S, Rossolini GM, Naas T.:
Performance evaluation of the UMIC© Cefiderocol to determine MIC in
Gram-negative bacteria.
J Antimicrob Chemother. 2023 Jul 5;78(7):1672-1676.
Linkevicius M, Bonnin RA, Alm E, Svartström O, Apfalter P, Hartl R, Hasman H, Roer L,
Räisänen K, Dortet L, Pfennigwerth N, Hans JB, Tóth Á, Buzgó L, Cormican M, Delappe N,
Monaco M, Giufrè M, Hendrickx AP, Samuelsen Ø, Pöntinen AK, Caniça M, Manageiro V,
Oteo-Iglesias J, Pérez-Vázquez M, Westmo K, Mäkitalo B, Palm D, Monnet DL, Kohlenberg
A.:
Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European
Union/European Economic Area, 2012 to June 2022.
Euro Surveill. 2023 May;28(19):2300209.
Salzberger B, Mellmann A, Bludau A, Ciesek S, Corman V, Dilthey A, Donker T, Eckmanns T,
Egelkamp R, Gatermann SG, Grundmann H, Häcker G, Kaase M, Lange B, Mielke M, Pletz MW,
Semmler T, Thürmer A, Wieler LH, Wolff T, Widmer AF, Scheithauer S.:
An appeal for strengthening genomic pathogen surveillance to improve pandemic preparedness
and infection prevention: the German perspective.
Infection. 2023 Aug;51(4):805-811.
Scheithauer S, Dilthey A, Bludau A, Ciesek S, Corman V, Donker T, Eckmanns T, Egelkamp R,
Grundmann H, Häcker G, Kaase M, Lange B, Mellmann A, Mielke M, Pletz M, Salzberger B,
Thürmer A, Widmer A, Wieler LH, Wolff T, Gatermann S, Semmler T.:
Establishment of genomic pathogen surveillance to strengthen pandemic preparedness and
infection prevention in Germany.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 Apr;66(4):443-449.
Hans JB, Pfennigwerth N, Neumann B, Pfeifer Y, Fischer MA, Eisfeld J, Schauer J, Haller S,
Eckmanns T, Gatermann S, Werner G.:
Molecular surveillance reveals the emergence and dissemination of NDM-5-producing
Escherichia coli high-risk clones in Germany, 2013 to 2019.
Euro Surveill. 2023 Mar;28(10):2200509.
Kresken M, Wohlfarth E, Wichelhaus TA, Gatermann SG, Pfennigwerth N, Eisfeld J, Seifert H;
German BL/BLI Study Group.:
Susceptibility of Multidrug-Resistant Escherichia coli, Klebsiella
pneumoniae, and Pseudomonas aeruginosa from Germany to Ceftolozane-Tazobactam,
Ceftazidime-Avibactam, and Imipenem-Relebactam.
Microb Drug Resist. 2023 Jan 9.
2022:
Sandfort M, Hans JB, Fischer MA, Reichert F, Cremanns M, Eisfeld J, Pfeifer Y, Heck A,
Eckmanns T, Werner G, Gatermann S, Haller S, Pfennigwerth N.:
Increase in NDM-1 and NDM-1/OXA-48-producing Klebsiella pneumoniae in Germany
associated with the war in Ukraine, 2022.
Euro Surveill. 2022 Dec;27(50):2200926.
Simon M, Gerlach RG, Pfeifer Y, Pfennigwerth N, Gatermann SG, Schröder A, Hiergeist A,
Hamprecht A, Rügamer T, Gessner A, Jantsch J.:
Increased zinc levels facilitate phenotypic detection of ceftazidime-avibactam resistance in
metallo-β-lactamase-producing Gram-negative bacteria.
Front Microbiol. 2022 Nov 22;13:977330.
Hecht J, Eisfeld J, Baum JHJ, Wagner-Wiening C, Leuze D, Zimnitskaya Y, Knautz D, Heinmüller
P, Gatermann S, Pfennigwerth N, Eckmanns T, Haller S.:
An Outbreak of Carbapenem-Resistant Acinetobacter baumannii in Multiple Federal
States in Germany.
Dtsch Arztebl Int. 2022 Jul 25;119(29-30):508-509.
Symanzik C, Esser J, Pfennigwerth N, Reuter C, Bronnert J, Grade M.:
Shewanella algae bacteraemia in a patient with a chronic ulcer after contact with
seawater on vacation in Turkey: A case report from a German maximum-care hospital.
New Microbes New Infect. 2022 Aug 29;48:101016.
Schauer J, Gatermann SG, Eisfeld J, Hans J, Pfennigwerth N.:
Detection of OXA-181-producing Pseudomonas aeruginosa in Germany.
Int J Med Microbiol. 2022 Jul;312(5):151557.
Petrak F, Herpertz S, Hirsch J, Röhrig B, Donati-Hirsch I, Juckel G, Meier JJ, Gatermann
S.:
Gut microbiota differs in composition between adults with type 1 diabetes with or without
depression and healthy control participants: a case-control study.
BMC Microbiol. 2022 Jun 28;22(1):169.
Goer A, Blanchard LS, Van Belkum A, Loftus KJ, Armstrong TP, Gatermann SG, Shortridge D,
Olson
BJ, Meece JK, Fritsche TR, Pompilio M, Halimi D, Franceschi C.:
Multicenter Evaluation of the Novel ETEST Fosfomycin for Antimicrobial Susceptibility
Testing of Enterobacterales, Enterococcus faecalis, and Staphylococcus
Species.
J Clin Microbiol. 2022 Jun 23:e0002122.
Rössler H, Flasbeck V, Gatermann S, Brüne M.:
Alterations of the gut microbiota in borderline personality disorder.
J Psychosom Res. 2022 Jul;158:110942.
Gatermann S, Das S, Dubreuil L, Giske CG, Kahlmeter G, Lina G, Lindemann C, MacGowan A,
Meletiadis J, Rossolini GM, Turnidge J, Cantón R.:
Expected phenotypes and expert rules are important complements to antimicrobial
susceptibility testing.
Clin Microbiol Infect. 2022 Jun;28(6):764-767.
Bender JK, Haller S, Pfeifer Y, Hogardt M, Hunfeld KP, Thürmer A, Zanuzdana A, Werner M,
Kunz B, Eisenberger D, Pfennigwerth N, Kempf VAJ, Werner G, Eckmanns T.:
Combined Clinical, Epidemiological, and Genome-Based Analysis Identified a Nationwide
Outbreak of Burkholderia cepacia Complex Infections Caused by Contaminated Mouthwash
Solutions.
Open Forum Infect Dis. 2022 Mar 9;9(5):ofac114.
Cremanns M, Lange F, Gatermann SG, Pfennigwerth N.:
Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella
pneumoniae.
J Antimicrob Chemother. 2022 May 29;77(6):1578-1585.
Schauer J, Gatermann SG, Eisfeld J, Hans JB, Ziesing S, Schlüter D, Pfennigwerth N.:
Characterization of GMB-1, a novel metallo-β-lactamase (MBL) found in three different
Enterobacterales species.
J Antimicrob Chemother. 2022 Apr 27;77(5):1247-1253.
Hildebrandt A, Hökelekli O, Uflacker L, Rudolf H, Paulussen M, Gatermann SG.:
Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care
Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated
Cross-Sectional Surveillance Study Over 1 Year.
Int J Environ Res Public Health. 2022 Feb 19;19(4):2402.
von Laer A, Eckmanns T, Zacher B, Pfennigwerth N, Gatermann SG, Reichert F, Diercke M,
Steffen G, Altmann D, Reuss A.:
Geographical differences of carbapenem non-susceptible Enterobacterales and
Acinetobacter spp. in Germany from 2017 to 2019.
Antimicrob Resist Infect Control. 2022 Feb 4;11(1):25.
2021:
Viehweger A, Blumenscheit C, Lippmann N, Wyres KL, Brandt C, Hans JB, Hölzer H, Irber L,
Gatermann SG, Lübbert C, Pletz MW, Holt KE, König B:
Context-aware genomic surveillance reveals hidden transmission of a carbapenemase-producing
Klebsiella pneumoniae.
Microb Genom. 2021; 7(12): 000741.
Nockelmann L, Cremanns M, Gatermann SG, Pfennigwerth N.:
Evaluation of the rCIM for carbapenemase detection in Enterobacterales and
Pseudomonas aeruginosa and description of the TSBrCIM, an optimized variant.
J Microbiol Methods. 2021 Nov;190:106345.
Hildebrandt A, Hökelekli O, Uflacker L, Rudolf H, Gatermann SG.:
COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees
in a secondary care hospital network in Germany: Intermediate results of a prospective
surveillance study.
Int J Hyg Environ Health. 2021 Jun;235:113771.
Kresken M, Korte-Berwanger M, Pfennigwerth N, Gatermann SG; Working Party Antimicrobial
Resistance of the Paul-Ehrlich-Society for Chemotherapy:
In vitro activity of ceftazidime/avibactam against ceftazidime-resistant
Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany.
J Glob Antimicrob Resist. 2021 Jun;25:337-338.
2020:
Heiden SE, Hübner NO, Bohnert JA, Heidecke CD, Kramer A, Balau V, Gierer W, Schaefer S,
Eckmanns T, Gatermann S, Eger E, Guenther S, Becker K, Schaufler K.:
A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of
extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition.
Genome Med. 2020 Dec 9;12(1):113.
Lötsch F, Albiger B, Monnet DL, Struelens MJ, Seifert H, Kohlenberg A; European
Antimicrobial Resistance Genes Surveillance Network (EURGen-Net) carbapenem-resistant
Acinetobacter baumannii capacity survey group; EURGen-Net carbapenem-resistant Acinetobacter
baumannii capacity survey group.:
Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant
Acinetobacter baumannii in Europe, 2019.
Euro Surveill. 2020 Nov;25(45):2001735.
David S, Cohen V, Reuter S, Sheppard AE, Giani T, Parkhill J; European Survey of
Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group; ESCMID Study Group for
Epidemiological Markers (ESGEM), Rossolini GM, Feil EJ, Grundmann H, Aanensen DM.:
Integrated chromosomal and plasmid sequence analyses reveal diverse modes of carbapenemase
gene spread among Klebsiella pneumoniae.
Proc Natl Acad Sci USA. 2020 Oct 6;117(40):25043-25054.
Pfennigwerth N, Gatermann SG, Körber-Irrgang B, Hönings R:
Phenotypic detection and differentiation of carbapenemase classes including OXA-48-like
enzymes in Enterobacterales and Pseudomonas aeruginosa by a highly specialized
MICRONAUT-S microdilution assay.
J Clin Microbiol. 2020 Oct 21;58(11):e00171-20.
Kahlmeter G, Cantón R, Giske CG, Turnidge J; EUCAST Steering Committee:
Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National
dissemination of EUCAST guidelines is a shared responsibility.
Clin Microbiol Infect. 2020 Aug 19:S1198-743X(20)30489-4. Online ahead of print.
Kresken M, Korte-Berwanger M, Gatermann SG, Pfeifer Y, Pfennigwerth N, Seifert H, Werner
G:
In vitro activity of cefiderocol against aerobic Gram-negative bacterial pathogens
from Germany.
Int J Antimicrob Agents. 2020 Oct;56(4):106128.
Kremer K, Kramer R, Neumann B, Haller S, Pfennigwerth N, Werner G, Gatermann S, Schroten H,
Eckmanns T, Hans JB:
Rapid spread of OXA-244-producing Escherichia coli ST38 in Germany: insights from an
integrated molecular surveillance approach; 2017 to January 2020.
Euro Surveill. 2020 Jun;25(25):2000923.
Wantia N, Gatermann SG, Rothe K, Laufenberg R:
New EUCAST definitions of S, I and R from 2019 - German physicians are largely not aware of
the changes.
Infection. 2020 Aug;48(4):597-606.
Ludden C, Lötsch F, Alm E, Kumar N, Johansson K, Albiger B, Huang TD, Denis O, Hammerum
AM, Hasman H, Jalava J, Räisänen K, Dortet L, Jousset AB, Gatermann S, Haller S,
Cormican M, Brennan W, Del Grosso M, Monaco M, Schouls L, Samuelsen Ø, Pirš M,
Cerar T, Oteo-Iglesias J, Pérez-Vázquez M, Sjöström K, Edquist P,
Hopkins KL, Struelens MJ, Palm D, Monnet DL, Kohlenberg A:
Cross-border spread of blaNDM-1- and blaOXA-48-positive
Klebsiella pneumoniae: a European collaborative analysis of whole genome sequencing and
epidemiological data, 2014 to 2019.
Euro Surveill. 2020 May;25(20):2000627.
Kresken M, Körber-Irrgang B, Korte-Berwanger M, Pfennigwerth N, Gatermann SG, Seifert H;
German Carbapenem Resistance Study Group:
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their
susceptibilities to ceftolozane-tazobactam in Germany.
Int J Antimicrob Agents. 2020 Jun;55(6):105959.
Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI, Eilers E, Bader V, Haase S,
Kaisler J, David C, Schneider R, Troisi R, Zent D, Hegelmaier T, Dokalis N, Gerstein S, Del
Mare-Roumani S, Amidror S, Staszewski O, Poschmann G, Sthler K, Hirche F, Balogh A, Kempa
S, Tröger P, Zaiss MM, Holm JB, Massa MG, Nielsen HB, Faissner A, Lukas C, Gatermann
SG,
Scholz M, Przuntek H, Prinz M, Forslund SK, Winklhofer KF, Müller DN, Linker RA, Gold
R,
Haghikia A:
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory
Mechanism.
Cell. 2020 Mar 19;180(6):1067-1080.e16
Poirel L, Nordmann P, de la Rosa JMO, Kutateladze M, Gatermann S, Corbellino M:
A phage-based decolonisation strategy against pan-resistant enterobacterial strains.
Lancet Infect Dis. 2020 May;20(5):525-526.
Hegelmaier T, Lebbing M, Duscha A, Tomaske L, T�nges L, Holm JB, Björn Nielsen H,
Gatermann
SG, Przuntek H, Haghikia A:
Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel
Cleansing Might Improve Motor Symptoms in Parkinson's Disease.
Cells. 2020 Feb 6;9(2).
Laufenberg Née Kohlmann R, Gatermann SG:
Species-specific epidemiology of AmpC production.
Clin Infect Dis. 2020 Feb 5:ciaa120.
Schauer J, Gatermann SG, Hoffmann D, Hupfeld L, Pfennigwerth N:
GPC-1, a novel class A carbapenemase found in a clinical Pseudomonas aeruginosa
isolate.
J Antimicrob Chemother. 2020 Apr 1;75(4):911-916.
2019:
Weber RE, Pietsch M, Frühauf A, Pfeifer Y, Martin M, Luft D, Gatermann S, Pfennigwerth
N, Kaase M, Werner G, Fuchs S:
IS26-Mediated Transfer of blaNDM-1 as the Main Route of Resistance
Transmission During a Polyclonal, Multispecies Outbreak in a German Hospital.
Front Microbiol. 2019 Dec 17;10:2817. doi: 10.3389/fmicb.2019.02817. eCollection 2019.
Schäfer E, Malecki M, Tellez-Castillo CJ, Pfennigwerth N, Marlinghaus L, Higgins PG,
Mattner F, Wendel AF:
Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three
medical centres in Cologne, Germany.
Antimicrob Resist Infect Control. 2019 Dec 30;8:208. doi: 10.1186/s13756-019-0665-5.
eCollection 2019.
David S, Reuter S, Harris SR, Glasner C, Feltwell T, Argimon S, Abudahab K, Goater R, Giani
T, Errico G, Aspbury M, Sjunnebo S; EuSCAPE Working Group; ESGEM Study Group, Feil EJ,
Rossolini GM, Aanensen DM, Grundmann H:
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by
nosocomial spread.
Nat Microbiol. 2019 Nov;4(11):1919-1929. doi: 10.1038/s41564-019-0492-8. Epub 2019 Jul 29.
Haller S, Kramer R, Becker K, Bohnert JA, Eckmanns T, Hans JB, Hecht J, Heidecke CD, H�bner
NO, Kramer A, Klaper K, Littmann M, Marlinghaus L, Neumann B, Pfeifer Y, Pfennigwerth N,
Rogge S, Schaufler K, Thürmer A, Werner G, Gatermann S:
Extensively drug-resistant Klebsiella pneumoniae ST307 outbreak, north-eastern
Germany, June to October 2019.
Euro Surveill. 2019 Dec;24(50). doi: 10.2807/1560-7917.ES.2019.24.50.1900734.
Lucena Baeza L, Pfennigwerth N, Hamprecht A.:
Rapid and Easy Detection of Carbapenemases in Enterobacterales in the Routine
Laboratory Using the New GenePOC Carba/Revogene Carba C Assay.
J Clin Microbiol. 2019 Aug 26;57(9).
Klare I, Bender JK, Fleige C, Kriebel N, Hamprecht A, Gatermann S, Werner G:
Comparison of VITEK® 2, three different gradient strip tests and broth microdilution for
detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs.
J Antimicrob Chemother. 2019 Oct 1;74(10):2926-2929.
Schauer J, Gatermann SG, Marschal M, Pfennigwerth N:
Genetic and biochemical characterization of FRI-3, a novel variant of the Ambler class A
carbapenemase FRI-1.
J Antimicrob Chemother. 2019 Oct 1;74(10):2891-2894.
Belda-Orlowski A, Pfennigwerth N, Gatermann SG, Korte-Berwanger M:
Evaluation and readout optimization of the rapid polymyxin NP test for the detection of
colistin-resistant Enterobacteriaceae.
J Med Microbiol. 2019 Aug;68(8):1189-1193.
Kohlmann R, Bähr T, Gatermann SG:
Effect of ampC derepression on cefepime MIC in Enterobacterales with
chromosomally encoded inducible AmpC β-lactamase.
Clin Microbiol Infect. 2019 Sep;25(9):1158.e1-1158.e4.
Pfennigwerth N, Kaminski A, Korte-Berwanger M, Pfeifer Y, Simon M, Werner G, Jantsch J,
Marlinghaus L, Gatermann SG:
Evaluation of six commercial products for colistin susceptibility testing in
Enterobacterales.
Clin Microbiol Infect. 2019 Nov;25(11):1385-1389.
Baeza LL, Pfennigwerth N, Greissl C, Göttig S, Saleh A, Stelzer Y, Gatermann SG,
Hamprecht A:
Comparison of five methods for detection of carbapenemases in Enterobacterales with
proposal of a new algorithm.
Clin Microbiol Infect. 2019 Oct;25(10):1286.e9-1286.e15.
Lange F, Pfennigwerth N, Höfken LM, Gatermann SG, Kaase M:
Characterization of mutations in Escherichia coli PBP2 leading to increased
carbapenem MICs.
J Antimicrob Chemother. 2019 Mar 1;74(3):571-576.
Rösner S, Kamalanabhaiah S, Kösters U, Kolbert M, Pfennigwerth N, Mack D:
Evaluation of a novel immunochromatographic lateral flow assay for rapid detection of
OXA-48, NDM, KPC and VIM carbapenemases in multidrug-resistant Enterobacteriaceae.
J Med Microbiol. 2019 Mar;68(3):379-381.
Topoulos S, Giesa C, Gatermann S, Fussen R, Lemmen S, Ewig S:
Analysis of acute respiratory infections due to influenza virus A, B and RSV during an
influenza epidemic 2018.
Infection. 2019 Jun;47(3):425-433.
Simon M, Gatermann S, Pfeifer Y, Reischl U, Gessner A, Jantsch J:
Evaluation of the automated BD Phoenix CPO Detect panel in combination with the β-CARBA
assay for detection and classification of carbapenemase-producing Enterobacterales.
J Microbiol Methods. 2019 Jan;156:29-33.
Hommelsheim C, Sichau M, Heipel R, Müller E, Gatermann S, Pfeifer M, Ewig S:
Predictors of Outcomes in Patients with Prolonged Weaning with Focus on Respiratory Tract
Pathogens and Infection.
Respiration. 2019;97(2):135-144. doi: 10.1159/000493430. Epub 2018 Oct 17.
Brolund A, Lagerqvist N, Byfors S, Struelens MJ, Monnet DL, Albiger B, Kohlenberg A; European
Antimicrobial Resistance Genes Surveillance Network EURGen-Net Capacity Survey Group.:
Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in
Europe, assessment by national experts from 37 countries, July 2018.
Euro Surveill. 2019 Feb;24(9). doi: 10.2807/1560-7917.ES.2019.24.9.1900123.
2018:
Steffen G, Pietsch M, Kaase M, Gatermann S, Werner G, Fuchs S, Pfeifer Y, Schmitt W, Adam H,
Eckmanns T, Haller S:
Overestimation of an outbreak of Enterobacter cloacae in a neonatal intensive care
unit in Germany, 2015.
Pediatr Infect Dis J. 2018 Dec 13. doi: 10.1097/INF.0000000000002264. [Epub ahead of print]
Lange F, Pfennigwerth N, Hartl R, Kerschner H, Achleitner D, Gatermann SG, Kaase M:
LMB-1, a novel family of class B3 MBLs from an isolate of Enterobacter cloacae.
J Antimicrob Chemother. 2018 Sep 1;73(9):2331-2335
Kohlmann R, Bähr T, Gatermann SG:
Species-specific mutation rates for ampC derepression in Enterobacterales with
chromosomally encoded inducible AmpC β-lactamase.
J Antimicrob Chemother. 2018 Jun 1;73(6):1530-1536.
Rösner S, Gehlweiler K, Küsters U, Kolbert M, Hübner K, Pfennigwerth N, Mack
D:
Comparison of two commercial carbapenemase gene confirmatory assays in multiresistant
Enterobacteriaceae and Acinetobacter baumannii-complex.
PLoS One. 2018 May 21;13(5):e0197839.
Becker L, Kaase M, Pfeifer Y, Fuchs S, Reuss A, von Laer A, Sin MA, Korte-Berwanger M,
Gatermann S, Werner G:
Genome-based analysis of Carbapenemase-producing Klebsiella pneumoniae isolates from
German hospital patients, 2008-2014.
Antimicrob Resist Infect Control. 2018 May 2;7:62.
Simon M, Richert K, Pfennigwerth N, Pfeifer Y, Reischl U, Gatermann S, Gessner A, Jantsch
J:
Carbapenemase detection using the β-CARBA test: Influence of test conditions on
performance and comparison with the RAPIDEC CarbaNP assay.
J Microbiol Methods. 2018 Apr;147:17-19.
van Almsick V, Ghebremedhin B, Pfennigwerth N, Ahmad-Nejad P:
Rapid detection of carbapenemase-producing Acinetobacter baumannii and
carbapenem-resistant Enterobacteriaceae using a bioluminescence-based phenotypic method.
J Microbiol Methods. 2018 Apr;147:20-25.
Hagemann JB, Pfennigwerth N, Gatermann SG, von Baum H, Essig A:
KPC-2 carbapenemase-producing Pseudomonas aeruginosa reaching Germany.
J Antimicrob Chemother. 2018 Mar 24. doi: 10.1093/jac/dky105. [Epub ahead of print]
Schaumburg F, Becker K, Gatermann SG:
Guidelines for Interpretation Required.
Dtsch Arztebl Int. 2018 Mar 16;115(11):191.
Becker L, Fuchs S, Pfeifer Y, Semmler T, Eckmanns T, Korr G, Sissolak D, Friedrichs M, Zill
E,
Tung ML, Dohle C, Kaase M, Gatermann S, Rüssmann H, Steglich M, Haller S, Werner G:
Whole Genome Sequence Analysis of CTX-M-15 Producing Klebsiella Isolates Allowed
Dissecting a Polyclonal Outbreak Scenario.
Front Microbiol. 2018 Feb 23;9:322.
Sobke A, Makarewicz O, Baier M, Bär C, Pfister W, Gatermann SG, Pletz MW, Forstner
C:
Empirical treatment of lower urinary tract infections in the face of spreading multidrug
resistance: in vitro study on the effectiveness of nitroxoline.
Int J Antimicrob Agents. 2018 Feb;51(2):213-220.
2017:
Lange F, Pfennigwerth N, Gerigk S, Gohlke F, Oberdorfer K, Purr I, Wohanka N, Roggenkamp A,
Gatermann SG, Kaase M:
Dissemination of blaOXA-58 in Proteus mirabilis isolates from
Germany.
J Antimicrob Chemother. 2017 May 1;72(5):1334-1339.
Pfennigwerth N, Lange F, Belmar Campos C, Hentschke M, Gatermann SG, Kaase M:
Genetic and biochemical characterization of HMB-1, a novel subclass B1
metallo-β-lactamase found in a Pseudomonas aeruginosa clinical isolate.
J Antimicrob Chemother. 2017 Apr 1;72(4):1068-1073.
Koroska F, Göttig S, Kaase M, Steinmann J, Gatermann S, Sommer J, Wille T, Plum G,
Hamprecht
A:
Comparison of Phenotypic Tests and an Immunochromatographic Assay and Development of a New
Algorithm for Detection of OXA-48-like Carbapenemases.
J Clin Microbiol. 2017 Mar;55(3):877-883.
Wendel AF, Kaase M, Autenrieth IB, Peter S, Oberhettinger P, Rieber H, Pfeffer K, MacKenzie
CR, Willmann M:
Protracted Regional Dissemination of GIM-1-Producing Serratia marcescens in Western
Germany.
Antimicrob Agents Chemother. 2017 Feb 23;61(3).
Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT,
Cantón R, Carmeli Y, Friedrich AW, Giske CG, Glupczynski Y,
Gniadkowski M, Livermore DM, Nordmann P, Poirel L, Rossolini GM, Seifert H, Vatopoulos A,
Walsh T, Woodford N, Monnet DL; European Survey
of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group:
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia
coli in the European survey of
carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.
Lancet Infect Dis. 2017 Feb;17(2):153-163.